Acadia Healthcare Company, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $3.3B | $3.2B | $2.9B | $2.6B | $2.3B |
| Cash from operations | $131.9M | $129.7M | $462.3M | $380.6M | $374.5M |
| Capital expenditure | $571.8M | $690.4M | $424.1M | $296.1M | $244.8M |
| Free cash flow | -$439.9M | -$560.7M | $38.2M | $84.4M | $129.7M |
| Share repurchases | $50.0M | — | — | — | — |
| Impairments | $1.0B | $17.3M | $9.8M | — | $24.3M |
| Total assets | $5.5B | $6.0B | $5.4B | $5.0B | $4.8B |
| Total liabilities | $3.4B | $2.8B | $2.5B | $2.1B | $2.2B |
| Total debt | $2.5B | $2.0B | $1.4B | $1.4B | $1.5B |
Shares outstanding 92.2M · Free float 87.4%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.